A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...
A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.
Opioids activate receptors in the brain to block pain signals and cause ... “Right now all the evidence suggests this has no addiction potential at all,” said Richard Rosenquist of the ...
The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
"This medication — which is a drug that inhibits sodium channels — works outside the brain on pain ... s non-opioid mechanism eliminates risks of misuse, addiction and respiratory depression ...